Financial reports
10-K
2023 FY
Annual report
21 Feb 24
10-Q
2023 Q3
Quarterly report
1 Nov 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
10-Q
2023 Q1
Quarterly report
3 May 23
ARS
2022 FY
Annual report to shareholders
13 Mar 23
10-K
2022 FY
Annual report
22 Feb 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
8 Jun 22
Current reports
8-K
Bausch + Lomb Announces Appointment of Karen L. Ling to Board of Directors
28 Feb 24
8-K
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and
21 Feb 24
8-K/A
Financial Statements and Exhibits
13 Nov 23
8-K/A
Departure of Directors or Certain Officers
7 Nov 23
8-K
Bausch + Lomb Announces Third-Quarter 2023 Results
1 Nov 23
8-K
Poised for Significant Growth in Prescription Dry Eye Segment
29 Sep 23
8-K
Bausch + Lomb Announces Pricing of Senior Secured Notes Offering
14 Sep 23
8-K
Other Events
11 Sep 23
8-K
Independent Auditors’ Report
6 Sep 23
8-K/A
Departure of Directors or Certain Officers
29 Aug 23
Registration and prospectus
S-8
Registration of securities for employees
2 Aug 23
S-3ASR
Automatic shelf registration
2 Aug 23
424B4
Prospectus supplement with pricing info
5 May 22
S-8
Registration of securities for employees
5 May 22
8-A12B
Registration of securities on exchange
5 May 22
S-1/A
IPO registration (amended)
28 Apr 22
S-1/A
IPO registration (amended)
30 Mar 22
S-1
IPO registration
13 Jan 22
DRS/A
Draft registration statement (amended)
19 Nov 21
DRSLTR
Correspondence regarding draft registration statement
19 Nov 21
Other
EFFECT
Notice of effectiveness
6 May 22
CERT
Certification of approval for exchange listing
5 May 22
CORRESP
Correspondence with SEC
3 May 22
CORRESP
Correspondence with SEC
3 May 22
CORRESP
Correspondence with SEC
28 Apr 22
CORRESP
Correspondence with SEC
28 Apr 22
UPLOAD
Letter from SEC
27 Apr 22
UPLOAD
Letter from SEC
13 Apr 22
CORRESP
Correspondence with SEC
13 Jan 22
UPLOAD
Letter from SEC
1 Dec 21